top | item 25728765 Lilly Alzheimer’s Drug Helped Patients in Small Trial 1 points| albertwang | 5 years ago |wsj.com 2 comments order hn newest albertwang|5 years ago Donanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placeboLink to press release: https://www.prnewswire.com/news-releases/lillys-donanemab-sl... waynekerr|5 years ago now that is good news....
albertwang|5 years ago Donanemab slowed cognitive and functional decline of patients with mild Alzheimer’s by 32% compared with placeboLink to press release: https://www.prnewswire.com/news-releases/lillys-donanemab-sl...
albertwang|5 years ago
Link to press release: https://www.prnewswire.com/news-releases/lillys-donanemab-sl...
waynekerr|5 years ago